Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03105336. IPD Sharing: YES. Countries: 2. Publications: 14.
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
ClinicalTrials.gov study NCT02181738. IPD Sharing: Not stated. Countries: 10. Publications: 6.
Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01865617. IPD Sharing: NO. Countries: 1. Publications: 11.
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02953509. IPD Sharing: NO. Countries: 3. Publications: 4.
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Tre
ClinicalTrials.gov study NCT03213691. IPD Sharing: Not stated. Countries: 2. Publications: 1.
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
ClinicalTrials.gov study NCT02104427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03057795. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003389. IPD Sharing: Not stated. Countries: 3. Publications: 4.
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
ClinicalTrials.gov study NCT02367040. IPD Sharing: NO. Countries: 37. Publications: 2.
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT00369681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00193479. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00118209. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
ClinicalTrials.gov study NCT02927769. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00078949. IPD Sharing: NO. Countries: 3. Publications: 7.
Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01733238. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03213678. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
ClinicalTrials.gov study NCT02055820. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03210714. IPD Sharing: Not stated. Countries: 2. Publications: 1.
GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00576758. IPD Sharing: Not stated. Countries: 17. Publications: 4.
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00601718. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.